Blog: Blog2

GPCR News

Apr 30, 20221 min read

Domain Therapeutics Raises $42m Series A Financing

May 2022 "Published: May 10, 2022 To accelerate clinical development of its best-in-class and first-in-class immuno-oncology programs...

Mar 31, 20221 min read

Ono Enters into Collaboration Agreement with Domain Therapeutics and Université de Montréal for ...

April 2022 Ono Enters into Collaboration Agreement with Domain Therapeutics and Université de Montréal for GPCR-Targeted Drug Discovery...

Feb 28, 20221 min read

Domain Therapeutics and Explicyte enter partnership agreement in immuno-oncology

March 2022 "Explicyte grants Domain Therapeutics exclusivity on data related to GPCR implicated in immunoresistance, to develop first-in...